Variant report
Variant | nsv895456 |
---|---|
Chromosome Location | chr10:56673719-56707648 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:56700000..56702785-chr10:56708737..56710411,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12767364 | chr10:56673719-56673720 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
2 | rs550438706 | chr10:56673728-56673729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570221728 | chr10:56673761-56673762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535697940 | chr10:56673776-56673777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555592359 | chr10:56673784-56673785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572412669 | chr10:56673787-56673788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138986737 | chr10:56673830-56673831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558151570 | chr10:56673835-56673836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143136667 | chr10:56673842-56673843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543892804 | chr10:56673884-56673885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147473841 | chr10:56673912-56673913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181800096 | chr10:56673915-56673916 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112334010 | chr10:56673932-56673933 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148464047 | chr10:56673945-56673946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs369572494 | chr10:56673952-56673953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12251229 | chr10:56673957-56673958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559654146 | chr10:56673969-56673970 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528417968 | chr10:56673984-56673985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs141722150 | chr10:56673990-56673991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150600502 | chr10:56674124-56674125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530463140 | chr10:56674142-56674143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1377992 | chr10:56674156-56674157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs188073699 | chr10:56693279-56693280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543715030 | chr10:56693298-56693299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78643735 | chr10:56693333-56693334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139853575 | chr10:56693336-56693337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575349420 | chr10:56693341-56693342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1670815 | chr10:56693368-56693369 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs548093668 | chr10:56693396-56693397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78216104 | chr10:56693402-56693403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1706750 | chr10:56693408-56693409 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs192849398 | chr10:56693463-56693464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537266039 | chr10:56693464-56693465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556949536 | chr10:56693495-56693496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs142263986 | chr10:56693526-56693527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 17426248 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56663000-56674000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr10:56673800-56674200 | Enhancers | HUVEC | blood vessel |
3 | chr10:56693200-56693600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |